Our Publications
For two decades at previously the University of Pittsburgh and Johns Hopkins University and now at the City University of New York Graduate School of Public Health & Health Policy (CUNY SPH), our PHICOR team has published over 295 publications in scientific peer-reviewed journals. This has included descriptions of work done directly with decision-makers at all levels — ranging from local, state, and federal leaders, as well as international leaders. Below are some examples.
The potential economic value of a therapeutic chagas disease vaccine for pregnant women to prevent congenital transmission
The potential economic value of a therapeutic chagas disease vaccine for pregnant women to prevent congenital transmission
Economic value of a therapeutic Chagas vaccine for inderterminate and chagasic cardiomyopathy patients
Economic value of a therapeutic Chagas vaccine for inderterminate and chagasic cardiomyopathy patients
The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission
The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission
Complementary paths to Chagas disease elimination: The impact of combining vector control with aetiological treatment
Complementary paths to Chagas disease elimination: The impact of combining vector control with aetiological treatment
Are the London Declaration’s 2020 goals sufficient to control Chagas disease? Modeling scenarios for the Yucantan Peninsula
Are the London Declaration’s 2020 goals sufficient to control Chagas disease? Modeling scenarios for the Yucantan Peninsula
How to determine if a model is right for neglected tropical disease decision making
How to determine if a model is right for neglected tropical disease decision making
Comparison and validation of two computational models of Chagas disease: a thirty year perspective from Venezuela
Comparison and validation of two computational models of Chagas disease: a thirty year perspective from Venezuela
The global economic and health burden of human hookworm infection
The global economic and health burden of human hookworm infection
Modeling the economic and epidemiological impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting
Modeling the economic and epidemiological impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting
Broad patterns in domestic vector-borne Trypanosoma cruzi transmission dynamics: synanthropic animals and vector control
Broad patterns in domestic vector-borne Trypanosoma cruzi transmission dynamics: synanthropic animals and vector control
The impact of human immunodeficiency virus (HIV) co-infection on the economic burden of cutaneous leishmaniasis (CL) in Brazil and potential value of new CL drug treatments
The impact of human immunodeficiency virus (HIV) co-infection on the economic burden of cutaneous leishmaniasis (CL) in Brazil and potential value of new CL drug treatments
A computational simulation model: The global economic burden of Chagas' disease
A computational simulation model: The global economic burden of Chagas' disease
Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia
Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia
Total economic cost and burden of Dengue in Nicaragua: 1996-2010
Total economic cost and burden of Dengue in Nicaragua: 1996-2010
Modeling the economic value of a Chagas’ disease therapeutic vaccine
Modeling the economic value of a Chagas’ disease therapeutic vaccine
The economic value of a visceral leishmaniasis vaccine in Bihar State, India
The economic value of a visceral leishmaniasis vaccine in Bihar State, India
The potential economic value of a hookworm vaccine
The potential economic value of a hookworm vaccine
The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America
The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America